×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NURO – neurometrix, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NURO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/20
02:06 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/12
02:11 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/4
02:09 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/24
02:06 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/16
04:03 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/8
01:36 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/23
02:08 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/15
02:10 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/25
04:02 pm
nuro
Form 8-K NeuroMetrix, Inc. For: Mar 21
Low
Report
Form 8-K NeuroMetrix, Inc. For: Mar 21
2/13
10:05 am
nuro
Form SCHEDULE 13G/A NeuroMetrix, Inc. Filed by: Radoff Bradley Louis
Neutral
Report
Form SCHEDULE 13G/A NeuroMetrix, Inc. Filed by: Radoff Bradley Louis
2/5
08:05 pm
nuro
Form 4 NeuroMetrix, Inc. For: Feb 02 Filed by: HIGGINS THOMAS T
Low
Report
Form 4 NeuroMetrix, Inc. For: Feb 02 Filed by: HIGGINS THOMAS T
2/5
08:04 pm
nuro
Form 4 NeuroMetrix, Inc. For: Feb 02 Filed by: Gozani Shai
Low
Report
Form 4 NeuroMetrix, Inc. For: Feb 02 Filed by: Gozani Shai
2/5
08:02 pm
nuro
Form 4 NeuroMetrix, Inc. For: Jan 01 Filed by: HIGGINS THOMAS T
Low
Report
Form 4 NeuroMetrix, Inc. For: Jan 01 Filed by: HIGGINS THOMAS T
2/5
08:01 pm
nuro
Form 4 NeuroMetrix, Inc. For: Jan 01 Filed by: Gozani Shai
Low
Report
Form 4 NeuroMetrix, Inc. For: Jan 01 Filed by: Gozani Shai
2/4
02:56 pm
nuro
Form 4/A NeuroMetrix, Inc. For: Feb 03 Filed by: Horowitz Joshua
Low
Report
Form 4/A NeuroMetrix, Inc. For: Feb 03 Filed by: Horowitz Joshua
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/10
NeuroMetrix Announces 2020 Annual Meeting of Shareholders Will Be Held in Virtual Meeting Format Only
42.1%
11/19 Neurometrix Inc (NASDAQ: NURO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 20.0%
11/18 NeuroMetrix Announces One-for-Ten Reverse Split 11.7%
1/23 Form SC 13G/A NeuroMetrix, Inc. Filed by: SABBY MANAGEMENT, LLC 8.4%
4/16 NeuroMetrix Reports Quell® Technology to be Used in NIH-Funded Trial Evaluating Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia 8.4%
12/19 Neurometrix Inc (NASDAQ: NURO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.3%
4/30 Form 4 NeuroMetrix, Inc. For: Apr 30 Filed by: Gozani Shai 7.3%
10/15 NeuroMetrix Announces Updates to Quell 2.0 Commercial Strategy 6.6%
1/22 NeuroMetrix, Inc. 2019 Financial Conference Call Rescheduled to Monday January 27, 2020 6.1%
1/27 NeuroMetrix. (NURO) CEO Dr. Shai Gozani on Q4 2019 Results - Earnings Call. [Seeking Alpha] 6.0%
11/19 Neurometrix Inc (NASDAQ: NURO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 20.0%
11/18 NeuroMetrix Announces One-for-Ten Reverse Split 11.7%
1/23 Form SC 13G/A NeuroMetrix, Inc. Filed by: SABBY MANAGEMENT, LLC 8.4%
4/16 NeuroMetrix Reports Quell® Technology to be Used in NIH-Funded Trial Evaluating Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia 8.4%
12/19 Neurometrix Inc (NASDAQ: NURO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.3%
4/30 Form 4 NeuroMetrix, Inc. For: Apr 30 Filed by: Gozani Shai 7.3%
10/15 NeuroMetrix Announces Updates to Quell 2.0 Commercial Strategy 6.6%
1/22 NeuroMetrix, Inc. 2019 Financial Conference Call Rescheduled to Monday January 27, 2020 6.1%
1/27 NeuroMetrix. (NURO) CEO Dr. Shai Gozani on Q4 2019 Results - Earnings Call. [Seeking Alpha] 6.0%
TOP News Decliners
4/14
NeuroMetrix rockets 171% but news scarce [Seeking Alpha]
-31.4%
1/27 NeuroMetrix Reports Q4 and Full Year 2019 Financial Results -27.6%
7/18 Form 8-K NeuroMetrix, Inc. For: Jul 18 -20.0%
4/15 Does Market Volatility Impact NeuroMetrix, Inc.'s (NASDAQ:NURO) Share Price? [Yahoo! Finance News] -14.6%
10/17 NeuroMetrix Reports Q3 2019 Financial Results -14.6%
10/9 Neurometrix Inc (NASDAQ: NURO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $0.50 price target on the stock. -11.7%
6/27 NeuroMetrix Provides Strategic Update -11.1%
5/7 NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology -9.7%
3/11 NeuroMetrix Provides Quell® Technology Commercial Strategy and Pipeline Update -9.6%
2/19 Form 424B5 NeuroMetrix, Inc. -9.1%
1/27 NeuroMetrix Reports Q4 and Full Year 2019 Financial Results -27.6%
7/18 Form 8-K NeuroMetrix, Inc. For: Jul 18 -20.0%
4/15 Does Market Volatility Impact NeuroMetrix, Inc.'s (NASDAQ:NURO) Share Price? [Yahoo! Finance News] -14.6%
10/17 NeuroMetrix Reports Q3 2019 Financial Results -14.6%
10/9 Neurometrix Inc (NASDAQ: NURO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $0.50 price target on the stock. -11.7%
6/27 NeuroMetrix Provides Strategic Update -11.1%
5/7 NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology -9.7%
3/11 NeuroMetrix Provides Quell® Technology Commercial Strategy and Pipeline Update -9.6%
2/19 Form 424B5 NeuroMetrix, Inc. -9.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: